Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Clin Exp Immunol

Retrieve available abstracts of 10 articles:
HTML format



Single Articles


    June 2022
  1. MA K, Que W, Hu X, Guo WZ, et al
    Combinations of anti-GITR antibody and CD28 superagonist ameliorated dextran sodium sulfate-induced mouse colitis.
    Clin Exp Immunol. 2022;208:340-350.
    PubMed     Abstract available


  2. SHARIFINEJAD N, Zaki-Dizaji M, Sepahvandi R, Fayyaz F, et al
    The clinical, molecular, and therapeutic features of patients with IL10/IL10R deficiency: a systematic review.
    Clin Exp Immunol. 2022;208:281-291.
    PubMed     Abstract available


    May 2021
  3. QIAN K, Yuan L, Wang S, Kuang Y, et al
    Inhibitor of apoptosis stimulating p53 protein (iASPP) protects against inflammatory bowel disease (IBD) in mice models by inhibiting the NF-kappaB signaling.
    Clin Exp Immunol. 2021 May 3. doi: 10.1111/cei.13613.
    PubMed     Abstract available


    February 2021
  4. LAN X, Liu F, Ma J, Chang Y, et al
    Leukocyte immunoglobulin-like receptor A3 is increased in IBD patients and functions as an anti-inflammatory modulator.
    Clin Exp Immunol. 2021;203:286-303.
    PubMed     Abstract available


    July 2020
  5. SASSON SC, Zaunders JJ, Nahar K, Munier CML, et al
    Mucosal-associated invariant T (MAIT) cells are activated in the gastrointestinal tissue of patients with combination ipilimumab and nivolumab therapy-related colitis in a pathology distinct from ulcerative colitis.
    Clin Exp Immunol. 2020 Jul 31. doi: 10.1111/cei.13502.
    PubMed     Abstract available


  6. LONG Y, Zhao X, Liu C, Xia C, et al
    Activated inducible co-stimulator-positive (ICOS(+) ) programmed death 1-positive (PD-1(+) ) Tfh cells indicate disease activity and severity in ulcerative colitis patients.
    Clin Exp Immunol. 2020 Jul 4. doi: 10.1111/cei.13485.
    PubMed     Abstract available


    June 2020
  7. SHAMRIZ O, Simon AJ, Lev A, Megged O, et al
    Exogenous interleukin-2 can rescue in-vitro T cell activation and proliferation in patients with a novel capping protein regulator and myosin 1 linker 2 mutation.
    Clin Exp Immunol. 2020;200:215-227.
    PubMed     Abstract available


    November 2019
  8. QURAISHI MN, Shaheen W, Oo YH, Iqbal TH, et al
    Immunological mechanisms underpinning faecal microbiota transplantation for the treatment of inflammatory bowel disease.
    Clin Exp Immunol. 2019 Nov 27. doi: 10.1111/cei.13397.
    PubMed     Abstract available


    May 2019
  9. ALVES VBF, de Sousa BC, Fonseca MTC, Ogata H, et al
    A single administration of human adipose tissue-derived mesenchymal stromal cells (MSC) induces durable and sustained long-term regulation of inflammatory response in experimental colitis.
    Clin Exp Immunol. 2019;196:139-154.
    PubMed     Abstract available


    February 2019
  10. THERRIEN A, Chapuy L, Bsat M, Rubio M, et al
    Recruitment of activated neutrophils correlates with disease severity in adult Crohn's disease.
    Clin Exp Immunol. 2019;195:251-264.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: